[Effects of vitrectomy as a treatment for proliferative diabetic retinopathy in young patients]

Ayumi Usui1, Masatoshi Kiyokawa, Itaru Kimura

  • 1Department of Ophthalmology, Juntendo University Urayasu Hospital, Japan. ayumi820226@hotmail.com

Insights

Vitrectomy improved vision in many young patients with proliferative diabetic retinopathy (PDR). However, neovascular glaucoma (NVG) remained a significant cause of vision loss in this demographic.

Area of Science:

  • Ophthalmology
  • Diabetology
  • Surgical Innovation

Context:

  • Proliferative diabetic retinopathy (PDR) poses a significant threat to vision, particularly in younger individuals.
  • Vitrectomy is a surgical intervention aimed at managing complications arising from PDR.
  • Understanding treatment outcomes in younger PDR patients is crucial for long-term visual health management.

Purpose:

  • To evaluate the efficacy and complications of vitrectomy in patients under 40 with PDR.
  • To identify risk factors associated with adverse outcomes, specifically neovascular glaucoma (NVG), following vitrectomy for PDR.

Summary:

  • Retrospective analysis of 60 eyes from 37 patients under 40 with PDR undergoing primary vitrectomy.
  • Visual acuity improved in 72% of cases; however, 22% experienced deterioration.
  • Neovascular glaucoma (NVG) was a primary cause of severe visual impairment, with male gender, hypertension, and proteinuria identified as risk factors.

Impact:

  • Vitrectomy can restore vision in a majority of young PDR patients.
  • Postoperative NVG is a critical complication in this population, necessitating further research into its multifactorial causes.
  • Lens preservation during vitrectomy may reduce the risk of NVG, suggesting potential modifications to surgical approaches.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...